🇺🇸 Lamotrigine tablets in United States
551 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 551
Most-reported reactions
- Drug Ineffective — 97 reports (17.6%)
- Toxicity To Various Agents — 84 reports (15.25%)
- Product Substitution Issue — 64 reports (11.62%)
- Rash — 49 reports (8.89%)
- Dizziness — 47 reports (8.53%)
- Nausea — 46 reports (8.35%)
- Drug Reaction With Eosinophilia And Systemic Symptoms — 45 reports (8.17%)
- Seizure — 42 reports (7.62%)
- Headache — 39 reports (7.08%)
- Intentional Overdose — 38 reports (6.9%)
Other Neurology approved in United States
Frequently asked questions
Is Lamotrigine tablets approved in United States?
Lamotrigine tablets does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Lamotrigine tablets in United States?
GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.